GWM
BMY icon

Graybill Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Graybill Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Hold
8,217
– – 0.13% 64
2026
Q1 		$498K Sell
8,217
-100
-1% -$5.83K 0.15% 64
2025
Q4 		$449K Hold
8,317
– – 0.13% 65
2025
Q3 		$375K Hold
8,317
– – 0.12% 70
2025
Q2 		$385K Sell
8,317
-250
-3% -$12.3K 0.13% 68
2025
Q1 		$523K Buy
+8,567
New +$499K 0.18% 63

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Graybill Wealth Management's BMY Position: Q2 2026 in Review

Graybill Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 8,217 shares worth $473K. The position accounts for 0.13% of the portfolio, ranked #64.

Graybill Wealth Management first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $523K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Graybill Wealth Management held 8,217 shares of Bristol-Myers Squibb worth $473K as of Q2 2026.
  • Graybill Wealth Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.13% of Graybill Wealth Management's portfolio in Q2 2026, its #64 holding.
  • Graybill Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • Graybill Wealth Management's Bristol-Myers Squibb position peaked at $523K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Graybill Wealth Management's 13F filing for Q2 2026, filed 17 Aug 2026.